责任编辑：小浪快报 进一步统计，近3个月内该股累计发生1笔大宗交易，合计成交金额为2200万元。该股近5个交易日累计 下跌5.21%，主力资金合计净流出1.07亿元。 1月28日，塞力医疗（维权）收跌4.71%，收盘价为23.29元，发生1笔大宗交易，合计成交量100万股， 成交金额2200万元。 第1笔成交价格为22.00元，成交100.00万股，成交金额2,200.00万元，溢价率为-5.54%，买方营业部为方 正证券股份有限公司湖北分公司，卖方营业部为财通证券股份有限公司上海分公司。 ...

| 交易日期 | | 券代码 成 | 成交价(元) 成交金额(万元) 成交量(*) 买入营业部 | | 奥出营业部 | 是否为专场 | | --- | --- | --- | --- | --- | --- | --- | | 026-01-28 | 塞力医疗 | 603716 22 22 2200 | 100 | 态焉嫣然劈堡有限 | 髮槽里킬劈纹葫芦 | Ka | 1月28日，塞力医疗大宗交易成交100万股，成交额2200万元，占当日总成交额的5.55%，成交价22元， 较市场收盘价23.29元折价5.54%。 ...

记者｜庞华玮 编辑｜包芳鸣 2026年伊始，A股市场迎来机构调研热潮。 截至1月26日，已有超过500家上市公司接受机构调研，其中工业机械、电子元件、电气设备、 半导体及汽车零配件等行业成为关注重点。 其中，"硬科技"与"出海"主线尤为突出。 在个股层面，大金重工、翔宇医疗、海天瑞声等14家公司获得超百家机构扎堆调研，其中大金 重工以209家机构调研数量位居第一。 机构调研热潮 新年伊始，机构调研活跃。Wind数据显示，截至1月26日，开年以来共有512家A股上市公司 接受了机构调研，调研总次数达801次。这一数据保持了较高的市场热度。 值得关注的是，个股层面，超百家机构扎堆调研14家A股公司，这些个股涨幅显著。 其中，大金重工以209家机构调研数量领先，这家电气设备公司受到了市场的广泛关注。 此外，医疗行业的翔宇医疗、爱朋医疗、美好医疗和博拓生物等分别获得208家、177家、125 家和117家机构调研；计算机行业的海天瑞声、熵基科技、能科科技和航天宏图，分别获得207 家、132家、107家和101家机构调研；汽车领域的超捷股份，获138家机构调研；工业机械领 域的耐普矿机，获132家机构调研；电子领域的 ...

待订立正式协议及达成或豁免(视情况而定)协议中可能订明的完成先决条件后，预期于可能出售事项完 成时，潜在买方及其一致行动人士将持有本公司已发行股本的50%以上。根据收购守则的规定，倘可能 出售事项落实，潜在买方及其一致行动人士须根据收购守则第26.1条就所有已发行股份(潜在买方及其 一致行动人士已拥有或同意收购的股份除外)提出强制性无条件全面要约。于本公告日期，董事会获 Meng A Capital告知尚未就可能出售事项订立正式协议，磋商仍在进行中，可能出售事项未必会进行。 公司将根据上市规则及收购守则适时另行刊发公告，以知会股东有关可能出售事项的任何进一步发展。 于本公告日期，Meng A Capital持有6.99亿股股份，占本公司已发行股本总额约73.60%。 于本公告日期，Meng A Capital由董事会主席、执行董事兼公司行政总裁孟宪震先生全资拥有。 GUANZE MEDICAL(02427)发布公告，公司董事会注意到，公司股份于2026年1月26日于联交所的价格 及成交量出现若干上升。公司获控股股东Meng A Capital Limited(Meng A Capital)告知，其正与一名潜在 ...

Core Viewpoint - The article emphasizes the importance of financial technology and healthcare sectors, highlighting the potential for investment opportunities through ETFs that focus on these areas, particularly in the context of China's economic policies and global health trends [3][4][6][7]. Financial Technology ETF (159851.SZ) - The "14th Five-Year Plan" reiterates the goal of accelerating the construction of a financial powerhouse, focusing on the development of "fintech" and "digital finance" [3]. - Advanced technologies such as generative AI and blockchain are rapidly being adopted, transforming the financial industry from an optional to a mandatory digitalization process [3]. - Leading financial institutions and IT companies are integrating AI into various applications, which is expected to drive cost reduction and innovation in the financial sector [4]. - The ETF tracks the CSI Financial Technology Theme Index, covering key areas like financial IT and internet finance, providing investors with an efficient tool to access the innovative benefits of the "finance + technology" intersection [4]. Healthcare ETF (512170.SH) - The emergence of the Nipah virus in India, with a mortality rate between 40% and 75%, is expected to catalyze short-term interest in the healthcare sector [6][7]. - In the medium to long term, the acceleration of innovative drugs entering international markets is seen as a core driver for the commercialization of the healthcare industry [6]. - China currently holds about 30% of the global pipeline for new drugs, ranking second worldwide, with 76 innovative drugs approved for market entry in 2025 [7]. - The total value of authorized transactions for innovative drugs from China is projected to exceed $130 billion, with over 150 transactions expected, marking a significant increase in China's global pharmaceutical capabilities [7].

GUANZE MEDICAL(02427)发布公告，该公司股份将于今天(26/1/2026)下午一时正起短暂停止买卖。 ...

睿昂基因公告，预计2025年年度实现归属于母公司所有者的净利润将出现亏损，实现归属于母公司所有 者的净利润为-3990.69万元到-5986.03万元。报告期内，受医疗行业环境影响，下游客户回款变慢，公 司根据坏账政策增加计提应收账款信用减值损失。 ...

Group 1 - The core viewpoint is that Zhao Bei, a fund manager, oversees seven funds, with the best quarterly performance being a decline of 11.44% for the Industrial Bank Pension Industry Stock A fund by the end of Q4 2025 [1] - During Zhao Bei's tenure as the manager of the Industrial Bank Healthcare Stock fund, the cumulative return was 192.7%, with an average annualized return of 10.08% [1] - The fund had 95 instances of stock adjustments, achieving a profit in 65 cases, resulting in a win rate of 68.42% [1] Group 2 - A notable stock adjustment example is the investment in Yingke Medical, which was bought in Q1 2020 and sold in Q1 2021, yielding an estimated return of 812.18% during the holding period, with a revenue growth of 17.37% from 2020 to 2021 [2] - Another example is the investment in Lepu Medical, purchased in Q4 2015 and sold in Q3 2020, which resulted in an estimated return of 99.44%, while the net profit increased by 245.93% from 2015 to 2020 [3] - A less successful case involved Aier Eye Hospital, bought in Q2 2021 and sold in Q2 2024, resulting in an estimated return of -63.63%, despite a net profit growth of 53.06% from 2021 to 2024 [4]

Group 1 - The core point of the article is that Sely Medical reported a total of 105,076 shareholders as of January 10, 2026 [2]

近10日内医疗健康R（480016）指数成份股做了调整，新纳入了1只股票，剔除了1只股票。 证券之星消息，1月16日，医疗健康R（480016）指数报收于7488.95点，跌0.88%，成交318.44亿元，换 手率1.07%。当日该指数成份股中，上涨的有13家，奕瑞科技以4.6%的涨幅领涨，下跌的有37家，华大 智造以6.61%的跌幅领跌。 医疗健康R（480016）指数十大成份股详情如下： 资金流向方面，医疗健康R（480016）指数成份股当日主力资金净流出合计3.81亿元，游资资金净流出 合计7.44亿元，散户资金净流入合计11.25亿元。成份股资金流向详情见下表： 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 ...